SMTL ID : 6b5m.1

Structure of PfCSP peptide 21 with human protective antibody CIS43

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.79 Å

Oligo State

hetero-1-1-1-mer

Ligands

4 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 3 residues within 4Å: Chain A: K.52, N.55, N.57 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:N.57 Water bridges: A:K.52, A:N.55 Salt bridges: A:K.52 SO4.2: 3 residues within 4Å: Chain B: P.8, D.9, S.10 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:D.9, B:D.9, B:S.10 SO4.3: 5 residues within 4Å: Chain A: P.131, K.217 Chain B: S.127, D.128, E.129 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:D.128, B:E.129 SO4.4: 3 residues within 4Å: Chain B: K.109, E.111, R.148 3 PLIP interactions: 3 interactions with chain B Water bridges: B:K.109 Salt bridges: B:K.109, B:R.148

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.5: 5 residues within 4Å: Chain A: S.140 Chain B: S.120, F.122, N.143, N.144 5 PLIP interactions: 3 interactions with chain B, 2 interactions with chain A Hydrogen bonds: B:S.120 Water bridges: B:S.120, B:N.143, A:S.140, A:T.191

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kisalu, N.K. et al., A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite. Nat. Med. (2018)

Release Date

2018-03-21

Peptides

CIS43 Fab Heavy chain: A
CIS43 Fab Light chain: B
pfCSP peptide 21: ASN-PRO-ASP-PRO-ASN-ALA-ASN-PRO-ASN-VAL-ASP-PRO-ASN: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

C
A

CIS43 Fab Heavy chain

CIS43 Fab Light chain

pfCSP peptide 21: ASN-PRO-ASP-PRO-ASN-ALA-ASN-PRO-ASN-VAL-ASP-PRO-ASN

Related Entries With Identical Sequence